vimarsana.com
Home
Live Updates
Novo Nordisk A/S (NYSE:NVO) Q1 2024 Earnings Call Transcript : comparemela.com
Novo Nordisk A/S (NYSE:NVO) Q1 2024 Earnings Call Transcript
Novo Nordisk A/S misses on earnings expectations. Reported EPS is $0.7 EPS, expectations were $0.77.
Related Keywords
Canada ,
China ,
United States ,
Denmark ,
Switzerland ,
France ,
America ,
American ,
Danish ,
Doug Langa ,
Michael Nedelcovych ,
Martin Holst Lange ,
Richard Vosser ,
Daniel Muusmann Bohsen ,
Camilla Sylvest ,
Daniel Bohsen ,
Lars Fruergaard ,
Novo Nordisk ,
Karsten Munk Knudsen ,
Louise Chen ,
European Renal Association Congress ,
Catalenta Global Contract Development ,
Cardior Pharmaceuticals ,
Novo Holdings ,
Head Of Development ,
Corporate Affairs ,
Manufacturing Organization ,
European Commission ,
Call Transcript May ,
Investor Relations ,
Executive Vice President ,
Commercial Strategy ,
North America Operations ,
Chief Financial Officer ,
Karsten Munk ,
Outcomes Trial ,
Select Cardiovascular Outcomes ,
North America ,
Diabetes Care ,
Holst Lange ,
Insulin Icodec ,
European Regulatory ,
Mimetic Bispecific Antibody ,
Munk Knudsen ,
Global Contract Development ,
North American ,
Kidney Outcomes Trial ,
Low Volatility Stocks ,
Buy According ,
comparemela.com © 2020. All Rights Reserved.